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SNAP-25 a membrane-associated protein of the nerve terminal, is specifically cleaved by botulinurn neurotoxins erotypes A and E, which cause 
human and animal botulism by blocking neurotransmitter release at the neuromuscular junction. Here we show that these two metallo-endopep- 
tidase toxins cleave SNAP-25 at two distinct carboxyl-terminal sites. Serotype A catalyses the hydrolysis of the Gln’97-Arg’98 peptide bond, while 
serotype E cleaves the Arg’80-Ile’8’ peptide linkage. These results indicate that the carboxyl-terminal region of SNAP-25 plays a crucial role in the 
multi-protein complex that mediates vesicle docking and fusion at the nerve terminal. 
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1. INTRODUCTION 
The flaccid paralysis of botulism is caused by a struc- 
turally related family of botulinurn neurotoxins 
(BoNT), composed of seven different serotypes 
(A,B,C,D,E,F, and G) [l-3]. BoNTs penetrate motor- 
neurons at the neuromuscular junction where they 
block acetylcholine release. Recent studies have demon- 
strated that these toxins are zinc-de~ndent endopepti- 
dases and that their effect on neuro~ans~ssion is medi- 
ated through the selective cleavage of proteins of the 
presynaptic terminal thought to be involved in docking 
and fusion of synaptic vesicles [4,5]. 
These neurotoxins exhibit both conformational as 
well as sequence specificity. Thus tetanus neurotoxin 
(TeNT) and BoNT/B, /D and /F have each been shown 
to cleave the synaptic protein VAMP/synaptobrevin at 
a single site that differs between these toxin serotypes 
[4-lo]. More recently, BoNT/A and IE were shown to 
recognize and cleave SNAP-25 (synaptosomal-associ- 
ated protein of 25 kDa) [11,12]. Unlike the vesicle-asso- 
ciated VAMP, SNAP-25 is located at the plasma mem- 
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Abbreviations: SNAP-25, synaptosomal-associated protein of 25 kDa; 
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BoNDA, botulinum neurotoxin serotype A; BoNT/E, botulinum neu- 
rotoxin serotype E; TeNT, tetanus neurotoxin; FA-22.5, 22.5 kDa 
SNAP-25 BoNT/A-generated fragment; FE-20.5,20.5 kDa SNAP-25 
BoNTIE-generated fragment; DTT, dithiothreitol. 
brane [13-l 51. Siillner et al. [16] have shown that both 
SNAP-25 and VAMP are components of a 20s multi- 
protein complex proposed to mediate vesicle docking 
and fusion. SNAP-25 also appears to be required for 
axonal growth during development and possibly nerve 
terminal plasticity in the mature nervous system [17,181. 
However, with the exception of sites for fatty acid acyl- 
ation [15], regions of the SNAP-25 polypeptide chain 
that mediate these inte~ol~~ar interactions have not 
been identified. 
Here we show that these two neurotoxins hydrolyse 
two different peptide bonds located in the COOH-termi- 
nal region, suggesting that this part of SNAP-25 is of 
critical importance for vesicle docking and fusion, 
2. MATERIALS AND METHODS 
2.1. Proteins and chemicals 
BoNTlA and fE were isolated and purified to remove traces of 
contaminant proteases as before [19,20]. Their serotype identity was 
assessed by the different electrophoretic mobility [21] and by five steps 
of amino acid sequencing. R~mbinant SNAP-25 was prepared by 
s&cloning the Ncol to EarnHI fragment bearing the entire protein 
coding region (717 bp) of the mouse cDNA plasmid clone ~8.52 [13] 
downstream of the T7 RNA transcription and protein translation 
signals of the T7 PET expression vector, pETlld (Novagen). The 
SNAP-25 expression plasmid was used to transform E. coli strain 
BL21 DE3 and soluble extracts were prepared after induction of T7 
RNA polymerase with IPTG. The recombinant SNAP-25 was col- 
lected as a 2555% ammonium sulfate precipitate, dialysed and frac- 
tionated by FPLC-MonoQ column (Pharmacia) with a 20-500 mM 
NaCl gradient (Prashant P. Metha, Jaime Jontes and Michael C. 
Wilson, in preparation). The recombinant protein was identified dur- 
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ing purification by immunobiotting with a specific polyclonal antise- 
rum [ 131. The protein was estimated to be 60-701 pure by Coomassie 
blue staining of SDS polyacrylamide gels. This was sufficient for the 
analysis of the pattern of neurotoxin proteolysis because no proteins 
of size lower than SNAP-25, which could interfere with the analysis, 
were present. Rabbit polyclonal antiserum against recombinant 
SNAP-25 was prepared as before [13] with a bacterial expressed re- 
combinant fusion protein, corresponding to residues 33-206 of the 
SNAP-25 polypeptide sequence prepared as above. Prior to immuni- 
zation, the recombinant SNAP-25 was partially purified by DEAE- 
Sephacel and Sephacryl S-200 (Pharmacia) chromatography (Richard 
A. Hart and Michael C. Wilson, unpublished results). 
2.2. Proteolytic activity o~ba~ul~~~ ne~ro~ox~ns A and E on synap- 
tosomes and recombinant SNAP-25 
BoNT/A and IE proteolysis of SNAP-25 in synaptosomes, isolated 
from rat brain cortex, was assayed as before 1121. BoNT proteolysis 
of recombinant SNAP-25 was performed as follows. Recombinant 
SNAP-25 in 50 mM Tris-HC!, 10 mM Nap,, 300 mM NaCI, 2 mM 
MgCl,, 0.3 mM CaCl,, 1 mM EDTA, 1 mM 2-mercaptoethanol, 0.25 
NaN,, pH 7.6 was treated with reduced BoNTIA or IE (200 nM final 
concentration) for 2.5 hours at 37°C. Samples were made 6.5% in 
trichloroacetic acid, centrifuged and pellets were subjected to SDS 
polyacrylamide gel electrophoresis and stained as before [ 121. Protein 
bands corresponding to the 22.5 kDa and 20.5 kDa SNAP-25 BoNT/A 
and /E-generated fragments were electroeluted, applied to ProSpin 
tubes and submitted to automatic Edman degradation with a gas- 
phase sequenator (Applied Biosystems model 470A) connected on-line 
with a phenylthiohydantoin amino acid analyzer with a Control Data 
Module model QOOA, programmed for five cycles of analysis. In par- 
allel, trichloroacetic acid supernatants were lyophilized, dissolved in 
100 ~1 of trifluoroacetic acid 0.05% and analyzed in Beckman Sistem 
Gold HPLC with a Cl8 Ultra-Sphere analytical column eluted with 
a @40% CH,CN/O.OS% trifluoroacetic acid linear gradient. Peptide 
peaks were collected and sequenced for ten cycles. 
3. RESULTS 
3.1. SNAP-25 is cleaved by EoNTlA and EoNTiE at two 
distinct sites 
SNAP-25 is a 206 residue nerve terminal protein, 
associated to the plasma membrane, possibly via palmi- 
toy1 chains linked to one or more of the four cysteine 
residues, located in the central region of the polypeptide 
chain [15]. As shown in Fig. lA, BoNT/A and IE con- 
vert synaptosomal SNAP-25 (23.3 kDa), to lower mo- 
lecular weight fragments, recognized by a polyclonal 
rabbit antiserum, raised against the recombinant fusion 
protein. While BoNT/A converts SNAP-25 to a 22.5 
kDa fragment (FA-22.5), similar to that described by 
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Fig. 1. Effect of BoNT/A and BoNT/E on synaptosomal and recombinant SNAP-25. (A) Rat brain synaptosomes were treated with buffer (Syn) 
or BoNTlA (Syn + BoNT/A) or BoNT/E (Syn + BoNT/E) as detailed in the experimental section. Samples were electrophoresed, blotted onto 
nitrocellulose and stained with a rabbit anti-recombinant SNAP-25 antiserum developed with anti rabbit alkaline phosphatase conjugated IgG. 
(B) Recombinant SNAP-25 (rSNAP-25) was incubated with buffer (rSNAP-25) or BoNT/A (rSNAP-25 f BoNT/A) or BoNTlE (rSNAP-25 
+BoNT/E), electrophoresed as the samples of panel A and visualized by silver staining or as done for the samples of panel A. 
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Fig. 2. Chromatographic analysis of the peptides generated by BoNT/A and BoNT/E proteolysis of recombinant SNAP-25 Recombinant SNAP-25 
@SNAP-25) was incubated with buffer or BoNT/A or BoNT/E, as the samples of Fig. 1, treated with trichloroacetic acid and the supematants 
were subjected to chromatographic analysis with a linear CH,CN/O.OS% trifluorocetic acid gradient as described in the experimental section. The 
lower panel shows the chromatogram of recombinant SNAP-25 and the upper panel reports a 10 x expansion of the region of retention times 16-20 
min showing the peptide peaks appearing upon incubation with BoNT/A (retention time 17.6 min) or with BoNT/E (18.3 min). These peaks do 
not overlap to any of the peaks present in the buffer-treated rSNAP-25. 
kDa fragment (FE-20.5). Since neither of these frag- 
ments are recognized by an antise~m raised against the 
twelve carboxyl-terminal residues of SNAP-25 [ 131, 
these results indicate that BoNTlA and IE cleave rat 
brain synaptosomal SNAP-25 at different sites, located 
in the 3 kDa COOH-terminal region of the protein. The 
small carboxyl-terminal fragments, however, were not 
detected by any of the available anti-SNAP-25 antisera, 
and nor we were able to identify them by Coomassie 
blue or silver staining, even after two-dimensional gel 
electrophoresis. These data, therefore, do not distin- 
guish whether the toxins cleave SNAP-25 at single or 
multiple sites. 
To discriminate between these possibilities, recombi- 
nant SNAP-25 proteolysis by BoNTlA or BoNT/E was 
studied. Fig. 1B shows that, when recombinant SNAP- 
25 was incubated with BoNTlA or BoNT/E, fragments 
of electrophoretic mobility identical to those of FA-22.5 
and FE-20.5 were generated. Interestingly, comparison 
of the silver staining and immunostaining profiles of 
SNAP-25 before and after treatment with the two neu- 
rotoxins indicates that the COOH-terminal residues of 
SNAP-25 form an immunodominant epitope and a mi- 
nority of the antibodies of this serum recognize other 
epitopes. Since the recombinant protein serves as an 
efficient and accurately cleaved substrate, these data 
demonstrate that accessory neuronal factors, including 
fatty acylation or membrane attachment at the nerve 
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FA-22.5 
BoNT/A . 198 
IMEKADSNKT BoNT/E . 
cleavage site 181 
Fig. 3. Amino acid sequence of mouse brain SNAP-25 and of the amino-terminal regions of the peptides generated by BoNT/A (above) and BoNTlE 
(below) determined by amino acid sequencing. The figure reports the c-DNA derived primary sequence of SNAP-25 [13] and the amino-terminal 
sequences of recombinant SNAP-25 fragments obtained as in Fig. 1. Recombinant SNAP-25 begins with Ala and the two BoNT generated fragments 
have the same amino-terminal sequence reported on the left part of the Figure. The sequences of the smaller fragments, isolated as shown in Fig. 
2, are reported on the right. 
terminal, are not necessary for the specific BoNT/A and 
/E proteolytic activity. 
Previously, evidence that BoNT/B, /D, /F and TeNT 
hydrolyse a single peptide bond in their target VAMP/ 
synaptobrevin, was provided by the cumulative esti- 
mated molecular weight of the two generated fragments 
[6,7,10]. Accordingly, silver staining of BoNT/E cleaved 
recombinant SNAP-25 revealed a faintly stained frag- 
ment ca. 3 kDa (undetectable after photographic print- 
ing) that together with the apparent 20.5 kDa mass of 
the larger fragment is consistent with the molecular 
weight of the intact protein (23.3 kDa). Unfortunately, 
the anticipated size of the COOH-terminal fragment 
produced by BoNT/A (ca. 1,000 Da, based on the de- 
crease in ii4, from 23.5 of SNAP-25 to 22.5 kDa of the 
larger fragment) would result in the expected fragment 
running in the dye front. 
mate, short side chain residues (such as alanine) at the 
amino termini [22]. This confirms that the sites of 
BoNT/A and /E proteolysis are both located in the 
SNAP-25 carboxyl-terminal region. 
3.2. Isolation and sequencing of the SNAP-25 fragments 
generated by BoNTIA and BoNTIE hydrolysis 
To identify the site of SNAP-25 proteolysis by BoNT/ 
To isolate the smaller toxin-generated SNAP-25 frag- 
ments, the SNAP-25-BoNT reaction mixture was acid 
precipitated, centrifuged and the clear supernatant was 
fractionated via HPLC over a C- 18 column. The chro- 
matograms reported in Fig. 2 show that fractionation 
of BoNT/A and /E-treated SNAP-25 resulted in the 
appearance of two peptide peaks with different reten- 
tion times, reflecting cleavage products which were not 
present in the intact recombinant SNAP-25 prepara- 
tion. The finding of only one additional peak in the 
BoNT/E-treated SNAP-25 samples indicates that this 
toxin does not cleave additionally at the site of BoNT/A 
proteolysis. However, BoNT/E still recognizes and 
cleaves SNAP-25 after BoNT/A proteolysis, as shown 
by the appearance in the chromatogram of a peptide 
peak of retention time intermediate between those of 
Fig. 2 (not shown). 
A and /E, the larger fragments, generated by digestion Fig. 3 reports the sequences of the peptides, isolated 
of the recombinant SNAP-25, were electroeluted from as shown in Fig. 2. RATKMLGSG corresponds to the 
the polyacrylamide gel and sequenced as described pre- nine carboxyl terminal residues of SNAP-25 and was 
viously [7,10,12]. As shown in Fig. 3, for both the obtained from the BoNT/A-induced small SNAP-25 
BoNT/A and /E derived fragments, the identical se- fragment. This sequence comprises a 920 Da peptide 
quence, AEDAD, was obtained. This corresponds to that would precisely account for the reduction of size of 
residues 2-6 of SNAP-25, as predicted from cDNA se- SNAP-25 caused by BoNT/A (Fig. l), indicating that 
quence [131. The lack of the amino terminal Met residue BoNT/A cleaves SNAP-25 at a single site, identified 
is explained by the efficient excision of the initiating here as the Gln1v7-Arg’v8 peptide bond. In contrast, the 
N-formyl-Met in E. coli, preferentially leaving penulti- sequence IMEKADSNKT was determined from the 
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3 kDa BoNT/E-derived fragment, indicating that this 
serotype hydrolyzes the Arg’80-Ile18’ peptide bond. The 
calculated molecular weight of the 181-206 SNAP-25 
segment (2,865 Da), well accounts for the decrease in A4, 
of SNAP-25 from 23.5 to 20.5 K, shown in Fig. 1. 
It is noteworthy that SNAP-25 contains other Q-R 
and R-I peptide bonds, but these peptide linkages are 
not hydrolyzed, indicating that BoNTIA and /E action, 
as well as that of the other BoNT serotypes, is not based 
solely on the recognition of the peptide bond. 
4. DISCUSSION 
BoNTIA and BoNT/E are zinc-endopeptidases that 
specifically recognize SNAP-25 as their nerve terminal 
substrate and cleave it at single, distinct sites within the 
carboxyl-terminal region. BoNT/A hydrolyzes the 
Gln’97-Arg198 peptide bond, while BoNT/E cleaves the 
Arg18’-Ile 18’ linkage. This definition of the mechanism 
of action of BoNT/A and /E leads to a molecular de- 
scription of the pathogenesis of botulism caused by 
these two BoNT serotypes. Moreover, a precise knowl- 
edge of their specificity is clearly a prerequisite for an 
appropriate use in the dissection of the molecular events 
underlying neuroexocytosis. 
Although BoNT/A and /E recognize the same nerve 
terminal target, they cleave it at two peptide bonds of 
very different chemical characteristics. BoNTIA recog- 
nizes a Gln at the P, site and an hydrophobic residue 
at the P,’ site, as TeTx, BoNT/B and BoNTlF do [7,10]. 
In contrast, BoNT/E recognizes a positively charged 
residue at the P, site and a hydrophobic residue at the 
P; site, as it is the case for BoNT/D [12]. Despite these 
differences, it is intriguing that BoNT/A and /E both 
cleave within 20 residues of each other at the SNAP-25 
COOH-terminus. In comparison, cleavage of VAMP/ 
synaptobrevin by TeNT, BoNT/B, /D and /F and of 
syntaxin by BoNT/C (Schiavo et al., in preparation) is 
more centrally targeted and it is thought to disrupt func- 
tion by dissociating the cytosolic part from its mem- 
brane-anchoring segment [3]. Interestingly, while previ- 
ous studies have not attributed functional importance 
to the carboxyl-terminal part of the protein, other re- 
gions have been implicated in SNAP-25 function. For 
example, the potential amphipathic helix-forming 
amino-terminal domain has been suggested to partici- 
pate in protein-protein interactions [13] and recent 
studies have shown that the segment 56-94, which in- 
cludes the palmitoylated cysteine quartet [I 51, is subject 
to alternative splicing that may affect neuronal mem- 
brane interactions [23,24]. It is remarkable, therefore, 
that the removal of only nine carboxyl-terminal residues 
of SNAP-25 by BoNTIA, is sufficient to impair neu- 
roexocytosis. The present indings suggest hat this pro- 
tein region plays a fundamental role in the recognition 
and/or regulation of the multi-protein neuroexocytosis 
machinery. 
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